NCT07060807 2026-04-16
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Immatics US, Inc.
Merck Sharp & Dohme LLC
NRG Oncology
NRG Oncology
Merck Sharp & Dohme LLC
SWOG Cancer Research Network
Akeso
RenovoRx
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sun Yat-sen University